✦ LIBER ✦

Histopathology and clinical outcome of NF1-associated vs. sporadic malignant peripheral nerve sheath tumors

✍ Scribed by Christian Hagel; Ulrich Zils; Matthias Peiper; Lan Kluwe; Stefan Gotthard; Reinhard E. Friedrich; David Zurakowski; Andreas von Deimling; Victor Felix Mautner

Publisher: Springer US
Year: 2006
Tongue: English
Weight: 150 KB
Volume: 82
Category: Article
ISSN: 0167-594X
DOI: 10.1007/s11060-006-9266-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Computer-assisted cytogenetic analysis o

Computer-assisted cytogenetic analysis of 51 malignant peripheral-nerve-sheath tumors: Sporadic Vs. neurofibromatosis-type-1-associated malignant schwannomas

✍ Boudewijn E.C. Plaat; Willemina M. Molenaar; Mirjam F. Mastik; Harald J. Hoekstr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB 👁 1 views

Cytogenetic studies in small groups of patients with malignant peripheral-nerve-sheath tumors (MPNST) revealed complex karyotypes with no consistent changes. A computerassisted cytogenetic analysis using a cytogenetic database was performed to determine recurrent cytogenetic alterations in 51 MPNSTs

Germline and somatic NF1 gene mutation s

Germline and somatic NF1 gene mutation spectrum in NF1-associated malignant peripheral nerve sheath tumors (MPNSTs)

✍ M. Upadhyaya; Lan Kluwe; G. Spurlock; Bisma Monem; E. Majounie; K. Mantripragada 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 1 views

## Communicated by Riccardo Fodde About 10% of neurofibromatosis type 1 (NF1) patients develop malignant peripheral nerve sheath tumors (MPNSTs) and represent considerable patient morbidity and mortality. Elucidation of the genetic mechanisms by which inherited and acquired NF1 disease gene variant

Analysis of chromosomal imbalances in sp

Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization

✍ Gunhild Mechtersheimer; Marta Otaño-Joos; Sibylle Ohl; Axel Benner; Thomas Lehne 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 2 views

Peripheral nerve sheath tumors arise either sporadically or in association with neurofibromatosis type 1 (von Recklinghausen's neurofibromatosis, NF1) or type 2. In this study, comprehensive screening for relative chromosome copy number changes was performed on 10 benign and 19 malignant peripheral

Molecular evolution of a neurofibroma to

Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings

✍ Gill Spurlock; Samantha J. L. Knight; Nick Thomas; Tim-Rasmus Kiehl; Abhijit Guh 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 851 KB

Genome-wide high-resolution analysis of

Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array

✍ Kiran K. Mantripragada; Teresita Díaz de Ståhl; Chris Patridge; Uwe Menzel; Robi 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

## Abstract Neurofibromatosis Type I (NF1) is an autosomal dominant disorder characterized by the development of both benign and malignant tumors. The lifetime risk for developing a malignant peripheral nerve sheath tumor (MPNST) in NF1 patients is ∼10% with poor survival rates. To date, the molecu

Microarray-based copy number analysis of

Microarray-based copy number analysis of neurofibromatosis type-1 (NF1)-associated malignant peripheral nerve sheath tumors reveals a role for Rho–GTPase pathway genes in NF1 tumorigenesis

✍ Meena Upadhyaya; Gill Spurlock; Laura Thomas; Nick S. T. Thomas; Mark Richards; 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 479 KB 👁 1 views

Neurofibromatosis type-1 (NF1) is associated with the growth of benign and malignant tumors. Approximately 15% of NF1 patients develop malignant peripheral nerve sheath tumors (MPNSTs), underlining the need to identify specific diagnostic/prognostic biomarkers associated with MPNST development. The